0.07
+0.0091(+13.87%)
Currency In USD
Address
4995 Murphy Canyon Road
San Diego, CA 92134
United States of America
Phone
760 471 8536
Sector
Healthcare
Industry
Biotechnology
Employees
7
First IPO Date
March 28, 2022
| Name | Title | Pay | Year Born |
| Dr. David Joszef Tapolczay | Chief Executive Officer & Director | 419,799 | 1959 |
| Mr. James Bligh | Interim Chief Financial Officer & Director | 533,345 | 1988 |
| Dr. Joanne M. Holland | Chief Scientific Officer | 0 | 1975 |
| Mr. Bill Begien | Senior Vice President of Investor Relations | 0 | N/A |
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.